vs

Side-by-side financial comparison of Prenetics Global Ltd (PRE) and RCM TECHNOLOGIES, INC. (RCMT). Click either name above to swap in a different company.

Prenetics Global Ltd is the larger business by last-quarter revenue ($92.0M vs $86.5M, roughly 1.1× RCM TECHNOLOGIES, INC.).

Prenetics (NASDAQ:PRE) is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer.

Exela Technologies, Inc. is an American business process automation ("BPA") company. It was created with the merger of SourceHOV LCC, Novitex Holdings, Inc. and Quinpario Acquisition Corp. 2.

PRE vs RCMT — Head-to-Head

Bigger by revenue
PRE
PRE
1.1× larger
PRE
$92.0M
$86.5M
RCMT

Income Statement — Q1 FY2023 vs Q1 FY2026

Metric
PRE
PRE
RCMT
RCMT
Revenue
$92.0M
$86.5M
Net Profit
$6.1M
Gross Margin
39.2%
28.1%
Operating Margin
9.2%
Net Margin
7.1%
Revenue YoY
12.4%
Net Profit YoY
112.9%
EPS (diluted)
$0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRE
PRE
RCMT
RCMT
Q1 26
$86.5M
Q3 25
$70.3M
Q2 25
$78.2M
Q1 25
$84.5M
Q4 24
$76.9M
Q3 24
$60.4M
Q2 24
$69.2M
Q1 24
$71.9M
Net Profit
PRE
PRE
RCMT
RCMT
Q1 26
$6.1M
Q3 25
$2.3M
Q2 25
$3.8M
Q1 25
$4.2M
Q4 24
$2.9M
Q3 24
$2.7M
Q2 24
$3.8M
Q1 24
$4.0M
Gross Margin
PRE
PRE
RCMT
RCMT
Q1 26
28.1%
Q3 25
27.6%
Q2 25
28.5%
Q1 25
26.0%
Q4 24
28.0%
Q3 24
29.6%
Q2 24
28.9%
Q1 24
28.3%
Operating Margin
PRE
PRE
RCMT
RCMT
Q1 26
9.2%
Q3 25
5.6%
Q2 25
8.4%
Q1 25
7.8%
Q4 24
8.2%
Q3 24
7.3%
Q2 24
8.4%
Q1 24
8.1%
Net Margin
PRE
PRE
RCMT
RCMT
Q1 26
7.1%
Q3 25
3.2%
Q2 25
4.8%
Q1 25
5.0%
Q4 24
3.7%
Q3 24
4.5%
Q2 24
5.4%
Q1 24
5.5%
EPS (diluted)
PRE
PRE
RCMT
RCMT
Q1 26
$0.80
Q3 25
$0.30
Q2 25
$0.50
Q1 25
$0.54
Q4 24
$0.38
Q3 24
$0.35
Q2 24
$0.47
Q1 24
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRE
PRE
RCMT
RCMT
Cash + ST InvestmentsLiquidity on hand
$2.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$46.0M
Total Assets
$134.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRE
PRE
RCMT
RCMT
Q1 26
$2.9M
Q3 25
$1.3M
Q2 25
$5.5M
Q1 25
$5.2M
Q4 24
$4.7M
Q3 24
$3.2M
Q2 24
$3.5M
Q1 24
$2.1M
Stockholders' Equity
PRE
PRE
RCMT
RCMT
Q1 26
$46.0M
Q3 25
$41.4M
Q2 25
$37.8M
Q1 25
$34.6M
Q4 24
$33.5M
Q3 24
$30.0M
Q2 24
$28.5M
Q1 24
$29.4M
Total Assets
PRE
PRE
RCMT
RCMT
Q1 26
$134.4M
Q3 25
$129.8M
Q2 25
$135.6M
Q1 25
$121.0M
Q4 24
$132.1M
Q3 24
$125.5M
Q2 24
$118.3M
Q1 24
$120.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRE
PRE
RCMT
RCMT
Operating Cash FlowLast quarter
$19.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.11×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRE
PRE
RCMT
RCMT
Q1 26
$19.0M
Q3 25
$-1.3M
Q2 25
$-7.9M
Q1 25
$16.7M
Q4 24
$-1.6M
Q3 24
$-4.3M
Q2 24
$5.7M
Q1 24
$6.4M
Free Cash Flow
PRE
PRE
RCMT
RCMT
Q1 26
Q3 25
$-1.8M
Q2 25
$-8.4M
Q1 25
$16.2M
Q4 24
$-2.6M
Q3 24
$-4.9M
Q2 24
$5.3M
Q1 24
$5.8M
FCF Margin
PRE
PRE
RCMT
RCMT
Q1 26
Q3 25
-2.5%
Q2 25
-10.7%
Q1 25
19.2%
Q4 24
-3.4%
Q3 24
-8.1%
Q2 24
7.7%
Q1 24
8.0%
Capex Intensity
PRE
PRE
RCMT
RCMT
Q1 26
Q3 25
0.7%
Q2 25
0.6%
Q1 25
0.5%
Q4 24
1.3%
Q3 24
0.9%
Q2 24
0.6%
Q1 24
0.9%
Cash Conversion
PRE
PRE
RCMT
RCMT
Q1 26
3.11×
Q3 25
-0.56×
Q2 25
-2.08×
Q1 25
3.98×
Q4 24
-0.57×
Q3 24
-1.58×
Q2 24
1.52×
Q1 24
1.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons